INTECH Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

INTECH Investment Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.38M	Buy	38,092 +1,655	+5%	+$56.6K	0.01%	875
2026 Q1	$1.2M	Sell	36,437 -72,418	-67%	-$3.07M	0.01%	930
2025 Q4	$5.04M	Buy	108,855 +22,146	+26%	+$927K	0.05%	370
2025 Q3	$3.03M	Sell	86,709 -23,966	-22%	-$833K	0.03%	567
2025 Q2	$3.27M	Buy	110,675 +36,767	+50%	+$1.05M	0.03%	504
2025 Q1	$2.21M	Buy	73,908 +6,776	+10%	+$207K	0.02%	697
2024 Q4	$1.92M	Buy	67,132 +57,455	+594%	+$1.9M	0.02%	730
2024 Q3	$374K	Buy	+9,677	New	+$345K	﹤0.01%	1384

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

INTECH Investment Management's COLL Position: Q2 2026 in Review

INTECH Investment Management increased its Collegium Pharmaceutical (COLL) stake by 4.5% in Q2 2026, buying an estimated $56.6K and bringing the position to 38,092 shares worth $1.38M. The position accounts for 0.01% of the portfolio, ranked #875.

INTECH Investment Management first reported a position in COLL in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.04M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

INTECH Investment Management held 38,092 shares of Collegium Pharmaceutical worth $1.38M as of Q2 2026.
INTECH Investment Management bought 1,655 Collegium Pharmaceutical shares in Q2 2026, an estimated $56.6K.
Collegium Pharmaceutical made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #875 holding.
INTECH Investment Management first reported a position in Collegium Pharmaceutical in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Collegium Pharmaceutical position peaked at $5.04M in Q4 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.